Huan Ma

ORCID

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Venues

Cell discovery

Cell research

This page only lists publications with an associated author ORCID identifier.

Publications

Huan Ma, Xinghai Zhang, Weihong Zeng, Junhui Zhou, Xiangyang Chi, Shaohong Chen, Peiyi Zheng, Meihua Wang, Yan Wu, Dan Zhao, Fanwu Gong, Haofeng Lin, Hancong Sun, Changming Yu, Zheng-Li Shi, Xiaowen Hu, Huajun Zhang, Teng-Chuan Jin, Sandra Chiu
A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration. Cell discovery 8 (1) (2022)
Huan Ma, Xinghai Zhang, Peiyi Zheng, Peter H Dube, Weihong Zeng, Shaohong Chen, Qingyu Cheng, Yunru Yang, Yan Wu, Junhui Zhou, Xiaowen Hu, Yan Xiang, Huajun Zhang, Sandra Chiu, Teng-Chuan Jin
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron. Cell research 32 (9) (2022)
Huan Ma, Xinghai Zhang, Weihong Zeng, Junhui Zhou, Xiangyang Chi, Shaohong Chen, Peiyi Zheng, Meihua Wang, Yan Wu, Dan Zhao, Fanwu Gong, Haofeng Lin, Hancong Sun, Changming Yu, Zheng-Li Shi, Xiaowen Hu, Huajun Zhang, Teng-Chuan Jin, Sandra Chiu
A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration. Cell discovery 8 (1) (2022)
Huan Ma, Xinghai Zhang, Weihong Zeng, Junhui Zhou, Xiangyang Chi, Shaohong Chen, Peiyi Zheng, Meihua Wang, Yan Wu, Dan Zhao, Fanwu Gong, Haofeng Lin, Hancong Sun, Changming Yu, Zheng-Li Shi, Xiaowen Hu, Huajun Zhang, Teng-Chuan Jin, Sandra Chiu
A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration. Cell discovery 8 (1) (2022)

Huan Ma.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Huan Ma